A prospective, randomized study of the comparative safety and efficacy of intraperitoneal imipenem versus vancomycin and netilmicin in the treatment of peritonitis on CAPD.
Anwar
N
N
Department of Renal Medicine, Manchester Royal Infirmary, U.K.
Merchant
M
M
Were
T
T
Tooth
A
A
Uttley
L
L
Gokal
R
R
D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009428:Netilmicin / Q000008:administration & dosage*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy*; D011446:Prospective Studies; D014640:Vancomycin / Q000008:administration & dosage*
D009428:Netilmicin; D014640:Vancomycin; D015378:Imipenem